These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36250913)

  • 1. Identification and validation of potential genotoxic impurities, 1,3-dichloro-2-propanol, and 2,3-dichloro-1-propanol, at subtle levels in a bile acid sequestrant, colesevelam hydrochloride, using hyphenated GC-MS technique.
    Kumar SRJ; Reddy JVR; Rao VK
    Biomed Chromatogr; 2023 Jan; 37(1):e5528. PubMed ID: 36250913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical determination of ethylenediamine impurity in tripelennamine hydrochloride by gas chromatography-mass spectrometry using phthalaldehyde as the derivatizing agent.
    Kousrali S; Kowtharapu LP; Mondal T
    Biomed Chromatogr; 2024 Jun; 38(6):e5850. PubMed ID: 38387606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous Determination of Genotoxic Impurities in Fudosteine Drugs by GC-MS.
    Gooty AR; Katreddi HR; S RR; Hunnur RK; Sharma HK; Masani NK
    J Chromatogr Sci; 2016 Sep; 54(8):1277-81. PubMed ID: 27261527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel analytical approach towards in-vitro bile acid binding studies to Colesevelam Hydrochloride tablets: An ultra-high performance liquid chromatography tandem mass spectrometric method.
    Raina S; Mungantiwar A; Halde S; Pandita N
    J Pharm Biomed Anal; 2019 Feb; 165():112-118. PubMed ID: 30529824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical Method Development for 19 Alkyl Halides as Potential Genotoxic Impurities by Analytical Quality by Design.
    Lee K; Yoo W; Jeong JH
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Validated GC-MS Method for the Determination of Genotoxic Impurities in Divalproex Sodium Drug Substance.
    Reddy SR; Reddy KH; Kumar MN; Reddy PM; Reddy JVR; Sharma HK
    J Chromatogr Sci; 2019 Feb; 57(2):101-107. PubMed ID: 30285097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colesevelam - a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia.
    Esan O; Viljoen A; Wierzbicki AS
    Expert Opin Pharmacother; 2022 Aug; 23(12):1363-1370. PubMed ID: 35968655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous and trace level quantification of two potential genotoxic impurities in valsartan drug substance using UPLC-MS/MS.
    Li S; Dong L; Tang K; Lan Z; Liu R; Wang Y; Wang R; Lin H
    J Pharm Biomed Anal; 2022 Apr; 212():114630. PubMed ID: 35158183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of potential genotoxic impurities in pharmaceuticals by two-dimensional gas chromatography with Deans switching and independent column temperature control using a low-thermal-mass oven module.
    David F; Jacq K; Sandra P; Baker A; Klee MS
    Anal Bioanal Chem; 2010 Feb; 396(3):1291-300. PubMed ID: 19949774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of chromatographic methods for the determination of genotoxic impurities in cloperastine fendizoate.
    García A; Rupérez FJ; Ceppa F; Pellati F; Barbas C
    J Pharm Biomed Anal; 2012 Mar; 61():230-6. PubMed ID: 22226040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects.
    Davidson MH; Dillon MA; Gordon B; Jones P; Samuels J; Weiss S; Isaacsohn J; Toth P; Burke SK
    Arch Intern Med; 1999 Sep; 159(16):1893-900. PubMed ID: 10493319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an analytical method for quantitative determination of three potentially genotoxic impurities in vildagliptin drug material using HPLC-MS.
    Al-Sabti B; Harbali J
    J Sep Sci; 2021 Jul; 44(13):2587-2595. PubMed ID: 33934507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a sensitive GC-MS method for the determination of alkylating agent, 4-chloro-1-butanol, in active pharmaceutical ingredients.
    Harigaya K; Yamada H; Yaku K; Nishi H; Haginaka J
    Chem Pharm Bull (Tokyo); 2014; 62(4):395-8. PubMed ID: 24695350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion.
    Hansen M; Scheltema MJ; Sonne DP; Hansen JS; Sperling M; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2016 Jun; 18(6):571-80. PubMed ID: 26888164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography.
    Kalauz A; Kapui I
    J Pharm Biomed Anal; 2022 Feb; 210():114544. PubMed ID: 34968997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive derivatization methods for the determination of genotoxic impurities in drug substances using hyphenated techniques.
    Raman NV; Prasad AV; Reddy KR
    J Pharm Biomed Anal; 2014 Feb; 89():276-81. PubMed ID: 24316427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colesevelam hydrochloride powder for oral suspension versus cholestyramine powder for oral suspension: comparison of acceptability and tolerability.
    Bays HE; Maki KC; Schmitz K
    Endocr Pract; 2011; 17(2):218-25. PubMed ID: 21041163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.
    Beysen C; Murphy EJ; Deines K; Chan M; Tsang E; Glass A; Turner SM; Protasio J; Riiff T; Hellerstein MK
    Diabetologia; 2012 Feb; 55(2):432-42. PubMed ID: 22134839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of
    Guo C; Liu Q; Zhang L; Zheng J; Wang Y; Yang S; Chu Z; Niu C; Xu Y
    Se Pu; 2020 Nov; 38(11):1288-1293. PubMed ID: 34213099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colesevelam.
    Melian EB; Plosker GL
    Am J Cardiovasc Drugs; 2001; 1(2):141-6; discussion 147-8. PubMed ID: 14728043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.